Comparison of the Efficacy and Safety of Glimepiride/Metformin Fixed Combination Versus Free Combination in Patients with Type 2 Diabetes: Multicenter, Randomized, Controlled Trial.
Seung Hwan Lee (Lee SH), In Kyu Lee (Lee IK), Sei Hyun Baik (Baik SH), Dong Seop Choi (Choi DS), Kyong Soo Park (Park KS), Ki Ho Song (Song KH), Kwan Woo Lee (Lee KW), Bong Soo Cha (Cha BS), Chul Woo Ahn (Ahn CW), Hyoung Woo Lee (Lee HW), Choon Hee Chung (Chung CH), Moon Suk Nam (Nam MS), Hong Sun Baek (Baek HS), Yong Ki Kim (Kim YK), Hyo Young Rhim (Rhim HY), Ho Young Son (Son HY)
Korean Diabetes J. 2006;30(6):466-475.   Published online 2006 Nov 1     DOI:
Citations to this article as recorded by Crossref logo
Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes
Y.-C. Hwang, M. Kang, C. W. Ahn, J. S. Park, S. H. Baik, D. J. Chung, H. C. Jang, K.-A. Kim, I.-K. Lee, K. W. Min, M. Nam, T. S. Park, S. M. Son, Y.-A. Sung, J.-T. Woo, K. S. Park, M.-K. Lee
International Journal of Clinical Practice.2013; 67(3): 236.     CrossRef
Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in
Bo-Hyung Kim, Kwang-Hee Shin, JaeWoo Kim, Kyoung Soo Lim, Kyu-pyo Kim, Jung-Ryul Kim, Joo-Youn Cho, Sang-Goo Shin, In-Jin Jang, Kyung-Sang Yu
Clinical Therapeutics.2009; 31(11): 2755.     CrossRef